BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22334040)

  • 1. Differential regulation of the nuclear factor-κB pathway by rabbit antithymocyte globulins in kidney transplantation.
    Urbanova M; Brabcova I; Girmanova E; Zelezny F; Viklicky O
    Transplantation; 2012 Mar; 93(6):589-96. PubMed ID: 22334040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
    Schulz T; Papapostolou G; Schenker P; Kapischke M
    Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low-dose antithymocyte globulins in kidney transplantation: results of a protocol of intermittent administration].
    Mourad G; Portales P; Garrigue V; Djamali A; Bouloux C; Chong G; Clot J
    Nephrologie; 2000; 21(5):253-8. PubMed ID: 11068775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion.
    LaCorcia G; Swistak M; Lawendowski C; Duan S; Weeden T; Nahill S; Williams JM; Dzuris JL
    Transplantation; 2009 Apr; 87(7):966-74. PubMed ID: 19352114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation.
    Bock HA; Gallati H; Zürcher RM; Bachofen M; Mihatsch MJ; Landmann J; Thiel G
    Transplantation; 1995 Mar; 59(6):830-40. PubMed ID: 7701577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
    Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction versus noninduction therapy in kidney transplantation: considering different PRA levels and different induction therapies.
    Castro MC; Araujo LM; Nahas WC; Arap S; David-Neto E; Ianhez LE
    Transplant Proc; 2004 May; 36(4):874-6. PubMed ID: 15194299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal retransplantation: a retrospective monocentric study.
    Ott U; Busch M; Steiner T; Schubert J; Wolf G
    Transplant Proc; 2008 Jun; 40(5):1345-8. PubMed ID: 18589102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
    Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
    Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midterm results of a prospective randomized comparison of two different rabbit-antithymocyte globulin induction therapies after heart transplantation.
    De Santo LS; Della Corte A; Romano G; Amarelli C; Onorati F; Torella M; De Feo M; Marra C; Maiello C; Giannolo B; Casillo R; Ragone E; Grimaldi M; Utili R; Cotrufo M
    Transplant Proc; 2004 Apr; 36(3):631-7. PubMed ID: 15110616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.
    Goggins WC; Pascual MA; Powelson JA; Magee C; Tolkoff-Rubin N; Farrell ML; Ko DS; Williams WW; Chandraker A; Delmonico FL; Auchincloss H; Cosimi AB
    Transplantation; 2003 Sep; 76(5):798-802. PubMed ID: 14501856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.
    Martins L; Fonseca I; Almeida M; Henriques AC; Dias L; Sarmento AM; Cabrita A
    Transplant Proc; 2005; 37(6):2755-8. PubMed ID: 16182802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATG induction therapy: long-term effects on Th1 but not on Th2 responses.
    Weimer R; Staak A; Süsal C; Streller S; Yildiz S; Pelzl S; Renner F; Dietrich H; Daniel V; Rainer L; Kamali-Ernst S; Ernst W; Padberg W; Opelz G
    Transpl Int; 2005 Feb; 18(2):226-36. PubMed ID: 15691277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithymocyte globulins suppress dendritic cell function by multiple mechanisms.
    Naujokat C; Berges C; Fuchs D; Sadeghi M; Opelz G; Daniel V
    Transplantation; 2007 Feb; 83(4):485-97. PubMed ID: 17318082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
    Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
    Transplant Proc; 2005 Oct; 37(8):3538-41. PubMed ID: 16298653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
    Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
    Clin Transplant; 2008; 22(5):645-50. PubMed ID: 18657156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.